Skip to main content

Table 1 Clinical characteristics and thyroid functions tests of patients with hyperthyroidism (GD and TNG) and controls.

From: Impact of severity, duration, and etiology of hyperthyroidism on bone turnover markers and bone mineral density in men

Parameters

GD (n = 31)

TNG (n = 21)

Controls (n = 25)

P1

P2

Age (years)

43 ± 10

44 ± 8

42 ± 11

>0.05

>0.05

Body weight (kg)

69.5 ± 8.0

68.0 ± 12.0

86.0 ± 10.0

<0.05

<0.05

Hight (cm)

170 ± 10

173 ± 10

173 ± 13

>0.05

>0.05

BMI (kg/m 2 )

27.5 ± 3.1

27.8 ± 2.8

30.2 ± 2.9

>0.05

>0.05

Duration of disease (years)

2.9 ± 1.2

3.0 ± 1.5

-

-

-

Serum TSH (uU/ml)

0.89 ± 0.47

1.01 ± 0.36

3.31 ± 0.76

<0.01

<0.01

Serum Free T3 (pmol/l)

6.14 ± 2.32

5.62 ± 1.42

4.57 ± 1.43

<0.01

<0.05

Serum Free T4 (pmol/l)

20.8 ± 6.2

19.8 ± 5.7

17.9 ± 4.26

<0.05

<0.05

  1. P1: Graves' diseases (GD) vs control
  2. P2: Toxic multinodular goiter (TNG) vs control
  3. Significant P < 0.05